BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18299280)

  • 1. Association of KRAS polymorphisms with risk for lung adenocarcinoma accompanied by atypical adenomatous hyperplasias.
    Kohno T; Kunitoh H; Suzuki K; Yamamoto S; Kuchiba A; Matsuno Y; Yanagitani N; Yokota J
    Carcinogenesis; 2008 May; 29(5):957-63. PubMed ID: 18299280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of CYP19A1 polymorphisms with risks for atypical adenomatous hyperplasia and bronchioloalveolar carcinoma in the lungs.
    Kohno T; Kakinuma R; Iwasaki M; Yamaji T; Kunitoh H; Suzuki K; Shimada Y; Shiraishi K; Kasuga Y; Hamada GS; Furuta K; Tsuta K; Sakamoto H; Kuchiba A; Yamamoto S; Kanai Y; Tsugane S; Yokota J
    Carcinogenesis; 2010 Oct; 31(10):1794-9. PubMed ID: 20688833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas.
    Sakamoto H; Shimizu J; Horio Y; Ueda R; Takahashi T; Mitsudomi T; Yatabe Y
    J Pathol; 2007 Jul; 212(3):287-94. PubMed ID: 17534846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.
    Chung JH; Choe G; Jheon S; Sung SW; Kim TJ; Lee KW; Lee JH; Lee CT
    J Thorac Oncol; 2009 Dec; 4(12):1490-5. PubMed ID: 19844187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular alterations in atypical adenomatous hyperplasia occurring in benign and cancer-bearing lungs.
    Gradowski JF; Mantha GS; Hunt JL; Dacic S
    Diagn Mol Pathol; 2007 Jun; 16(2):87-90. PubMed ID: 17525677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of a human lung adenocarcinoma susceptibility locus, possibly syntenic to the mouse Pas1 locus, in the vicinity of the D12S1034 locus on chromosome 12p11.2-p12.1.
    Yanagitani N; Kohno T; Sunaga N; Kunitoh H; Tamura T; Tsuchiya S; Saito R; Yokota J
    Carcinogenesis; 2002 Jul; 23(7):1177-83. PubMed ID: 12117776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma.
    Sivakumar S; Lucas FAS; McDowell TL; Lang W; Xu L; Fujimoto J; Zhang J; Futreal PA; Fukuoka J; Yatabe Y; Dubinett SM; Spira AE; Fowler J; Hawk ET; Wistuba II; Scheet P; Kadara H
    Cancer Res; 2017 Nov; 77(22):6119-6130. PubMed ID: 28951454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung.
    Westra WH; Baas IO; Hruban RH; Askin FB; Wilson K; Offerhaus GJ; Slebos RJ
    Cancer Res; 1996 May; 56(9):2224-8. PubMed ID: 8616876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significant association between EGFR-mutated lung adenocarcinoma and past illness from gastric cancer or uterine myoma: its implication in carcinogenesis.
    Okudela K; Woo T; Yazawa T; Ogawa N; Tajiri M; Masuda M; Kitamura H
    Lung Cancer; 2009 Dec; 66(3):287-91. PubMed ID: 19362747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential molecular changes during multistage pathogenesis of small peripheral adenocarcinomas of the lung.
    Soh J; Toyooka S; Ichihara S; Asano H; Kobayashi N; Suehisa H; Otani H; Yamamoto H; Ichimura K; Kiura K; Gazdar AF; Date H
    J Thorac Oncol; 2008 Apr; 3(4):340-7. PubMed ID: 18379350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung.
    Morandi L; Asioli S; Cavazza A; Pession A; Damiani S
    Lung Cancer; 2007 Apr; 56(1):35-42. PubMed ID: 17241687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of KRAS mutations and Ki-67 expression in stage I lung adenocarcinomas.
    Woo T; Okudela K; Yazawa T; Wada N; Ogawa N; Ishiwa N; Tajiri M; Rino Y; Kitamura H; Masuda M
    Lung Cancer; 2009 Sep; 65(3):355-62. PubMed ID: 19162366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchioloalveolar neoplasia.
    Kitamura H; Okudela K
    Int J Clin Exp Pathol; 2010 Nov; 4(1):97-9. PubMed ID: 21228931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
    Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
    Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical adenomatous hyperplasia of the lung: a probable forerunner in the development of adenocarcinoma of the lung.
    Mori M; Rao SK; Popper HH; Cagle PT; Fraire AE
    Mod Pathol; 2001 Feb; 14(2):72-84. PubMed ID: 11235908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nras and Kras mutation in Japanese lung cancer patients: Genotyping analysis using LightCycler.
    Sasaki H; Okuda K; Kawano O; Endo K; Yukiue H; Yokoyama T; Yano M; Fujii Y
    Oncol Rep; 2007 Sep; 18(3):623-8. PubMed ID: 17671710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation profile during multistage progression of pulmonary adenocarcinomas.
    Chung JH; Lee HJ; Kim BH; Cho NY; Kang GH
    Virchows Arch; 2011 Aug; 459(2):201-11. PubMed ID: 21494759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A SNP in a let-7 microRNA complementary site in the KRAS 3' untranslated region increases non-small cell lung cancer risk.
    Chin LJ; Ratner E; Leng S; Zhai R; Nallur S; Babar I; Muller RU; Straka E; Su L; Burki EA; Crowell RE; Patel R; Kulkarni T; Homer R; Zelterman D; Kidd KK; Zhu Y; Christiani DC; Belinsky SA; Slack FJ; Weidhaas JB
    Cancer Res; 2008 Oct; 68(20):8535-40. PubMed ID: 18922928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population-based mapping of pulmonary adenoma susceptibility 1 locus.
    Dragani TA; Hirohashi S; Juji T; Kawajiri K; Kihara M; Ono-Kihara M; Manenti G; Nomoto T; Sugimura H; Genka K; Yokota J; Takahashi T; Mitsudomi T; Nagao M
    Cancer Res; 2000 Sep; 60(18):5017-20. PubMed ID: 11016621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.